Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients

NCT02919111 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

299

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Ga-68 labeled PSMA-11 PET

Sponsor

University of California, San Francisco